Warning on Compounded GLP-1s; Ketoacidosis Deaths; Axon Stim for Diabetic Nerve Pain

(MedPage Today) -- The Obesity Society, Obesity Action Coalition, and Obesity Medicine Association released a joint statement warning against the use of compounded GLP-1 receptor agonists. Novo Nordisk resumed shipments of its 1.7-mg dose of semaglutide...
Source: MedPage Today Endocrinology - Category: Endocrinology Source Type: news